(Press-News.org) In women who use donor eggs to become pregnant through in vitro fertilization (IVF), those who are obese are just as likely to become pregnant as normal weight women, according to a new report.
Studies have shown that obesity is associated with lower chances of pregnancy using IVF, but most of this work is limited to women using their own eggs. Research on outcomes for obese women using donor eggs has had mixed results.
The new analysis by investigators at Washington University School of Medicine in St. Louis and the University of California-Los Angeles pooled and analyzed data from more than 4,700 women in earlier studies.
The results are available online in the journal Human Reproduction.
"Our study suggests that obesity does not significantly affect whether a woman will become pregnant with donor eggs," said first author Emily Jungheim, MD, assistant professor of obstetrics and gynecology at Washington University School of Medicine. "This supports the argument that doctors shouldn't discourage obese women from pursuing treatment if they need donor eggs to conceive."
The report, a meta-analysis, included patients from five earlier studies conducted over the past decade, in addition to data from 123 egg donor recipients from the Washington University Infertility and Reproductive Medicine Center.
Many IVF programs have arbitrary body mass index (BMI) restrictions that help them determine whether women can receive treatment. These cutoffs, according to Jungheim, need to be re-examined. "There's still a lot about obesity that we don't know when it comes to reproduction," she said.
Investigators aren't sure whether the quality of a woman's eggs or her uterus are most affected by obesity. As a result, several studies have focused on donor egg recipients to provide some clues.
In this analysis, obesity (defined as a BMI over 30) was not associated with a difference in pregnancy rates when compared with pregnancy rates in women with a normal BMI. The data from this study also indicates that obesity was not associated with differences in the rates of miscarriage or live birth among obese women who used donor eggs, when compared with women of normal weight. However, live births and miscarriages were not reported in all of the studies.
"In general, most obese women who want to get pregnant are eventually able to conceive," Jungheim said. "We need to find out what specifically goes wrong in obese women who don't. We think other factors besides BMI are involved."
INFORMATION:
Funding for this research comes from the Women's Reproductive Health Research Program of the National Institutes of Health (NIH). NIH Grant number (K12HD063086).
Jungheim ES, Schon SB, Schulte MB, DeUgarte, DA, Fowler SA and Tuuli MG. IVF outcomes in obese donor oocyte recipients: a systematic review and meta-analysis. Human Reproduction vol. 28, (8), published online July 11, 2013.
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
URL: https://news.wustl.edu/news/Pages/25644.aspx
Obesity doesn't reduce chance of getting pregnant with donor eggs
2013-08-01
ELSE PRESS RELEASES FROM THIS DATE:
Breath analysis reliably indicates presence, level of infection in mice, UCI study finds
2013-08-01
Irvine, Calif., July 31, 2013 — Breath analysis may prove to be an accurate, noninvasive way to quickly determine the severity of bacterial and other infections, according to a UC Irvine study appearing online today in the open-access journal PLOS ONE.
Employing a chemical analysis method developed for air pollution testing, UC Irvine microbiologists and chemists were able to correlate inflammation levels in laboratory mice to the amount of naturally produced carbon monoxide and other gases in breath samples.
The findings point to human applications of this technology ...
New target identified for food allergy therapy
2013-08-01
DENVER - Researchers at National Jewish Health have identified an enzyme that is essential to the allergic reaction to peanuts. Blocking the enzyme's activity in sensitized mice prevented diarrhea and inflammation, and reduced levels of several proteins associated with allergies. The findings, published online in the Journal of Allergy and Clinical Immunology, identify the enzyme, known as Cyp11a1, as a potential target for treatment of increasingly common and potentially deadly food allergy.
"Right now, we have no therapy for food allergy other than to avoid the allergenic ...
Promising compound could offer new treatment for heart failure
2013-08-01
Heart failure occurs when the heart cannot pump enough blood to meet the body's needs. It's a very common condition, affecting about six million people in the United States, but current therapies are not adequately effective at improving health and preventing deaths. A study published by Cell Press August 1st in the journal Cell reveals the key role of a family of molecules known as bromodomain and extraterminal domain (BET) proteins in activating genes that contribute to heart failure. The study also demonstrates that a BET-inhibiting drug can protect against heart failure ...
Trouble waking up? Camping could set your clock straight
2013-08-01
If you have trouble going to sleep at night and waking up for work or school in the morning, a week of camping in the great outdoors might be just what you need. That's according to evidence reported on August 1 in Current Biology, a Cell Press publication, showing that humans' internal biological clocks will tightly synchronize to a natural, midsummer light-dark cycle, if only they are given the chance.
A week of exposure to true dawn and dusk with nights lit only by a campfire's glow had the biggest effect on people who might otherwise describe themselves as night owls. ...
JCI early table of contents for Aug. 1, 2013
2013-08-01
Prolactin reduces arthritis inflammation
Inflammatory joint diseases such as rheumatoid arthritis are the result of cartilage damage and loss. Chondrocytes are the only cells that are found in cartilage and their death is linked to decreased cartilage health. In this issue of the Journal of Clinical Investigation, Carmen Clapp and colleagues at the National University of Mexico identify prolactin as a potential treatment for inflammatory joint disease. Prolactin treatment prevented chondrocyte death and associated cartilage degradation. In a rat model of inflammatory ...
Prolactin reduces arthritis inflammation
2013-08-01
Inflammatory joint diseases such as rheumatoid arthritis are the result of cartilage damage and loss. Chondrocytes are the only cells that are found in cartilage and their death is linked to decreased cartilage health. In this issue of the Journal of Clinical Investigation, Carmen Clapp and colleagues at the National University of Mexico identify prolactin as a potential treatment for inflammatory joint disease. Prolactin treatment prevented chondrocyte death and associated cartilage degradation. In a rat model of inflammatory arthritis, prolactin treatment reduced inflammation, ...
Identification of a molecule linking bone loss and bone formation
2013-08-01
Bone integrity requires skeletal remodeling, which involves both bone formation and resorption. It has been previously shown that the formation of new bone is triggered by degradation of older bone. However, it is unknown how these two processes coordinate for skeletal maintenance. In this issue of the Journal of Clinical Investigation, Sunao Takeshita and colleagues at the National Center for Geriatrics and Gerontology identify a protein, CTHRC1 that is secreted by bone adsorbing cells (osteoclasts) and helps initiate bone formation. The authors found that CTHRC1 secretion ...
Defense against bacterial infection in chronic granulomatous disease
2013-08-01
Patients suffering from chronic granulomatous disease (CGD) are prone to recurrent and potentially life threatening bouts of infection due to the inability of phagocytic cells to kill invading microorganisms. Normal phagocytes release reactive oxygen compounds in response to infection, but this defense is lacking in phagocytes of people with CGD. In the current issue of the Journal of Clinical Investigation, Griffin Rodgers and colleagues at the National Institutes of Health identify a neutrophil granule protein, OLFM4 as a potential therapeutic target for CGD patients. ...
We each live in our own little world -- smellwise
2013-08-01
There are some smells we all find revolting. But toward a handful of odors, different people display different sensitivities—some can smell them, while some can't, or some find them appealing, while others don't. A pair of studies appearing online on August 1 in the journal Current Biology, a Cell Press publication, now identifies the genetic differences that underpin the differences in smell sensitivity and perception in different individuals. The researchers tested nearly 200 people for their sensitivity for ten different chemical compounds that are commonly found in ...
Neuroscientists find protein linked to cognitive deficits in Angelman syndrome
2013-08-01
A team of neuroscientists has identified a protein in laboratory mice linked to impairments similar to those afflicted with Angelman syndrome (AS)—a condition associated with symptoms that include autism, intellectual disability, and motor abnormalities.
The findings appear in the journal Cell Reports.
"By isolating a protein that contributes to cognitive deficits in Angelman syndrome, these findings mark a step forward in not only addressing AS, but perhaps other developmental disorders as well," said Eric Klann, a professor in New York University's Center for Neural ...